EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Brian Lima
Carmelo A. Milano
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schroder, J. N.
Right arrow Articles by Milano, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schroder, J. N.
Right arrow Articles by Milano, C. A.
Related Collections
Right arrow Congestive Heart Failure
Right arrow Transplantation - heart

Eur J Cardiothorac Surg 2006;29:848-850
© 2006 Elsevier Science NL


Case report

Cardiac transplantation following ACORN CorCap device implantation

Jacob N. Schroder a , Brian Lima a , Joseph G. Rogers b , Carmelo A. Milano a , *

a Department of Surgery, Division of Cardiothoracic Surgery, Duke University Medical Center, Durham, NC 27710, United States
b Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC 27710, United States

Received 20 October 2005; received in revised form 16 December 2005; accepted 2 February 2006.

* Corresponding author. Address: Box 3043, Department of Surgery, Duke University Medical Center, Durham, NC 27703, United States. Tel.: +1 919 684 3243; fax: +1 919 684 8563. (Email: milan002{at}mc.duke.edu).

Passive ventricular restraint devices, such as the ACORN CorCap, have been introduced as a potential therapy for congestive heart failure (CHF). These mesh devices act as a mechanical support for the dilated heart. Due to incorporation of the device to the epicardium, concerns about the feasibility of reoperation following CorCap placement have been raised. This case illustrates that although technically challenging, reoperation for heart transplantation after CorCap implantation is feasible and safe.

Key Words: Congestive heart failure • Passive restraint device • Transplantation • CorCap




This article has been cited by other articles:


Home page
CirculationHome page
Y. Yildirim, H. Naito, M. Didie, B. C. Karikkineth, D. Biermann, T. Eschenhagen, and W.-H. Zimmermann
Development of a Biological Ventricular Assist Device: Preliminary Data From a Small Animal Model
Circulation, September 11, 2007; 116(11_suppl): I-16 - I-23.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.